Background. Pulmonary hypertension is a dreaded disease associated with considerable
morbidity and mortality. The pulmonary hypertension developing due to chronic respiratory …

Commonly described smoker's lung disease are emphysema, chronic bronchitis, lung
cancer, and interstitial lung disease (ILD). CPFE is heterogenous lung disease documented …

Interstitial lung disease (ILD) is a clinical syndrome of various etiologies and histopathologic
categorization that when clinically significant, impair respiratory function. Progressive …

Broadly speaking, a rare disease is any disease that affects a small percentage of people in
a population. Although there is no more specific, widely accepted definition of a rare …

Background Pulmonary hypertension (PH) is an important complication of interstitial lung
disease (ILD). The aim of the present study was to investigate characteristics and prognosis …

Background The mortality risk of chronic interstitial lung disease (ILD) is currently assessed
using the ILD-GAP score. The present study evaluates whether the addition of …

Non-invasive markers of pulmonary hypertension in interstitial lung disease: is cardiopulmonary
exercise testing the Holy Grail? - Abstract - Europe PMC Sign in | Create an account …

In 2005, the combined pulmonary fibrosis and emphysema (CPFE) was first defined as a
distinct entity, which comprised centrilobular or paraseptal emphysema in the upper …

Background: Interstitial lung diseases (ILD) comprise a diverse group of heterogeneous
entities. Epidemiology, clinical profile and prognosis of interstitial lung diseases widely vary …

Rheumatoid arthritis (RA) is a chronic immune-mediated inflammatory disease of unknown
origin. Although it mainly affects joints, it can have extra-articular manifestations, with the …